Literature DB >> 15381011

Acylated flavonoids and phenol glycosides from Veronica thymoides subsp. pseudocinerea.

Iclal Saracoglu1, Mehtap Varel, U Sebnem Harput, Akito Nagatsu.   

Abstract

A new acylated flavone glucoside, 3'-hydroxyscutellarein 7-O-(6''-O-protocatechuoyl)-beta-glucopyranoside (1), and a new phenol glucoside, 3,5-dihydroxyphenethyl alcohol 3-O-beta-glucopyranoside (6) were isolated from Veronica thymoides subsp. pseudocinerea together with seven known flavone, phenol and lignan glycosides; 3'-hydroxyscutellarein 7-O-(6''-O-trans-feruloyl)-beta-glucopyranoside (2), 3'-hydroxy, 6-O-methylscutellarein 7-O-beta-glucopyranoside (3), luteolin 7-O-beta-glucopyranoside (4), isoscutellarein 7-O-(6'''-O-acetyl)-beta-allopyranosyl (1''' --> 2'')-beta-glucopyranoside (5), 3,4-dihydroxyphenethyl alcohol 8-O-beta-glucopyranoside (7), benzyl alcohol 7-O-beta-xylopyranosyl (1" --> 2')-beta-glucopyranoside (8), and (+)-syringaresinol 4'-O-beta-glucopyranoside (9). Compounds 2, 3 and 7-9 were reported for the first time in the genus Veronica. The structures of the isolates were determined by means of spectroscopic (UV, IR, 1D and 2D NMR, HR ESI-MS) methods. Isolated compounds (1-7) exhibited potent radical scavenging activity against the 2,2-diphenyl-1-picrylhydrazyl (DPPH) radical.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15381011     DOI: 10.1016/j.phytochem.2004.05.011

Source DB:  PubMed          Journal:  Phytochemistry        ISSN: 0031-9422            Impact factor:   4.072


  2 in total

1.  5-Alkylresorcinol glucosides from the leaves of Grevillea robusta Allan Cunningham.

Authors:  Yukiko Yamashita; Katsuyoshi Matsunami; Hideaki Otsuka; Takakazu Shinzato; Yoshio Takeda
Journal:  J Nat Med       Date:  2010-05-27       Impact factor: 2.343

2.  Bioprospecting the Metabolome of Plant Urtica dioica L.: A Fast Dereplication and Annotation Workflow in Plant Metabolomics.

Authors:  Keshab Bhattarai; Babita Paudel; Sujan Dahal; Parasmani Yadav; Niraj Aryal; Bikash Baral; Hari Datta Bhattarai
Journal:  Evid Based Complement Alternat Med       Date:  2022-04-21       Impact factor: 2.650

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.